There are 169 resources available
49P - Computational approaches for the development of cyclin-dependent kinase 1 inhibitors as anti-cancer compounds
Presenter: Vineeta Teotia
Session: Cocktail and Poster Display session
Resources:
Abstract
50P - Comparison of pelitinib, tepotinib, and docetaxel efficacy according to the copy number or gene alteration status of the EGFR, MET, HRAS, KRAS, and NRAS genes
Presenter: Dae Young Zang
Session: Cocktail and Poster Display session
Resources:
Abstract
51P - Discovery of novel CDK12/13 inhibitors as cyclin K molecular glues targeting metastatic breast and gastric cancer
Presenter: Anna Moon
Session: Cocktail and Poster Display session
Resources:
Abstract
52P - miRNA-based therapeutics for triple-negative breast cancer
Presenter: Bulent Ozpolat
Session: Cocktail and Poster Display session
Resources:
Abstract
53P - PHI-501 as a potent pan-RAF/DDRs inhibitor suppresses colorectal cancer cell proliferation and overcomes BRAF inhibitor resistance
Presenter: Sue Min Kim
Session: Cocktail and Poster Display session
Resources:
Abstract
54P - Resistance to MAPK pathway inhibition in BRAF-V600E mutant colorectal cancer can be overcome with insulin receptor/insulin-like growth factor-1 receptor inhibitors
Presenter: Layla El Bouazzaoui
Session: Cocktail and Poster Display session
Resources:
Abstract
55P - High snail expression and activation of mTOR promote liver recurrence after hepatic metastasectomy for colorectal cancer
Presenter: Seçil Aksoy
Session: Cocktail and Poster Display session
Resources:
Abstract
56P - Rapid and accurate prediction of TKI treatment response in advanced EGFR-mutant non-small cell lung cancer using the CODRP platform
Presenter: Chan Kwon Park
Session: Cocktail and Poster Display session
Resources:
Abstract
57P - The role of mir29-a and mir143 on the anti-apoptotic MCL-1/cIAP-2 genes expression in EGFR mutated non-small cell lung carcinoma patients
Presenter: Zahra Abrehdari-Tafreshi
Session: Cocktail and Poster Display session
Resources:
Abstract
58P - Novel nanoACPA delivery system presents antitumor effect on ectopic non-small cell lung cancer xenograft model
Presenter: Ozge Boyacioglu
Session: Cocktail and Poster Display session
Resources:
Abstract